BFCH to Acquire EVERMIND™ Beverage, Strengthening Cognitive Health Portfolio

BitFrontier Capital Holdings, Inc. (OTC: BFCH), operating as EVERMIND Holdings, Inc., has entered into a binding Letter of Intent (LOI) to acquire ERApeutics, LLC, the creator of the EVERMIND™ beverage platform. This acquisition is poised to add a science-supported, IP-backed consumer brand to BFCH's portfolio, reinforcing its $0.01 equity benchmark and supporting its strategy for an eventual uplisting and expanded capital approach.

The EVERMIND™ beverage, a physician-formulated, plant-based protein shake, is designed to offer both immediate and long-term cognitive health benefits. With its shelf-stable nature and readiness for commercialization, EVERMIND™ represents a significant addition to BFCH's assets. The transaction, valued at $4,000,000, involves the issuance of 400,000,000 restricted common shares at a fixed price of $0.01 per share, aligning with BFCH's previous financial strategies.

Dr. Jordan Balencic, CEO of BFCH, emphasized the platform nature of EVERMIND™, comparing its potential impact on cognitive health to that of Celsius in the metabolism space. The acquisition includes six proprietary nootropic and adaptogenic formulations, an R&D pipeline, academic research, and a fully integrated e-commerce platform, positioning BFCH for significant growth in the functional beverage market.

With the functional beverage sector gaining institutional interest, as evidenced by recent high-profile investments and acquisitions, BFCH's move to acquire EVERMIND™ places it at the forefront of the cognitive health and wellness industry. The transaction, expected to close within 60 to 90 days, will see EVERMIND™ operating as a wholly owned subsidiary of EVERMIND Labs, with potential for future spin-offs.

This strategic acquisition not only strengthens BFCH's balance sheet by adding IP-backed assets but also supports its OTCQB uplisting strategy. By eliminating toxic debt and structuring asset acquisitions at a fixed equity benchmark, BFCH is laying the groundwork for future institutional engagement and growth in the competitive wellness and performance sectors.

For more details on the EVERMIND™ beverage and its cognitive health benefits, visit https://evermindholdings.com/evermind-beverage/.